Clade Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Clade Therapeutics's estimated annual revenue is currently $15.5M per year.
- Clade Therapeutics's estimated revenue per employee is $155,000
- Clade Therapeutics's total funding is $87M.
Employee Data
- Clade Therapeutics has 100 Employees.
- Clade Therapeutics grew their employee count by 49% last year.
Clade Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | President / CBO, Co-Founder | Reveal Email/Phone |
3 | Co-Founder And COO | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | Associate Director Quality Systems | Reveal Email/Phone |
6 | Director, Bioscience Immunology Early Respiratory & Immunology | Reveal Email/Phone |
7 | Associate Director, Translational Immunology | Reveal Email/Phone |
8 | Associate Biosample Manager | Reveal Email/Phone |
9 | Senior Manager, Analytical Development | Reveal Email/Phone |
10 | Principal Research Associate | Reveal Email/Phone |
Clade Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Clade Therapeutics?
Clade Therapeutics is a seed-stage cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located at Kendall Square’s LaunchLabs, was recently launched by an exceptional group of academic leaders and successful bioentrepreneurs converging stem cell biology, immunology, regenerative medicine, and gene editing into the next-generation of stem cell-derived medicines.
keywords:N/A$87M
Total Funding
100
Number of Employees
$15.5M
Revenue (est)
49%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.5M | 100 | 32% | $283M |
#2 | $20M | 100 | 3% | $15M |
#3 | $31M | 100 | -12% | N/A |
#4 | $3.5M | 100 | 16% | N/A |
#5 | $3.5M | 100 | 59% | N/A |